MDS (MYELODYSPLASTIC SYNDROME)
Clinical trials for MDS (MYELODYSPLASTIC SYNDROME) explained in plain language.
Never miss a new study
Get alerted when new MDS (MYELODYSPLASTIC SYNDROME) trials appear
Sign up with your email to follow new studies for MDS (MYELODYSPLASTIC SYNDROME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Weekly shot vs daily injection: race to stop bleeding after transplant
Disease control Not yet recruitingThis study is for adults with MDS or aplastic anemia who receive a donor stem cell transplant. After transplant, patients often struggle with low platelets, which increases bleeding risk. Researchers are comparing a once-weekly injection (romiplostim) against a daily injection (r…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
15-Year watch begins for patients who got experimental cancer cell therapy
Disease control Not yet recruitingThis study will monitor the long-term safety of an experimental cell therapy called ARD103 for 15 years. It will track 49 patients who previously received the therapy for relapsed or hard-to-treat acute myeloid leukemia or myelodysplastic syndrome. The goal is to understand any d…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Sponsor: ARCE Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test gentler prep for blood cancer transplants
Disease control Not yet recruitingThis study is testing the safety of adding a drug called venetoclax to a standard, lower-intensity chemotherapy regimen given before a stem cell transplant. The goal is to see if this combination can better control acute myeloid leukemia (AML) or high-risk myelodysplastic syndrom…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New transplant prep could boost survival for blood cancer patients
Disease control Not yet recruitingThis study aims to find out which of two chemotherapy drugs works better to prepare patients for a stem cell transplant for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). It will compare treosulfan and melphalan in 220 adult patients who are at higher risk for si…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC